Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats - Rahn, E J; Zvonok, A M; Thakur, G A (J Pharm Exp Ther, 2008)